AT554101T - New activinrezeptor and applications thereof - Google Patents

New activinrezeptor and applications thereof

Info

Publication number
AT554101T
AT554101T AT06827481T AT06827481T AT554101T AT 554101 T AT554101 T AT 554101T AT 06827481 T AT06827481 T AT 06827481T AT 06827481 T AT06827481 T AT 06827481T AT 554101 T AT554101 T AT 554101T
Authority
AT
Austria
Prior art keywords
activinrezeptor
applications
new
Prior art date
Application number
AT06827481T
Other languages
German (de)
Inventor
Hq Han
Keith Soo-Nyung Kwak
Xiaolan Zhou
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US73227005P priority Critical
Application filed by Amgen Inc filed Critical Amgen Inc
Priority to PCT/US2006/043044 priority patent/WO2007053775A1/en
Publication of AT554101T publication Critical patent/AT554101T/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/30Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
AT06827481T 2005-11-01 2006-11-01 New activinrezeptor and applications thereof AT554101T (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US73227005P true 2005-11-01 2005-11-01
PCT/US2006/043044 WO2007053775A1 (en) 2005-11-01 2006-11-01 Novel activin receptor and uses thereof

Publications (1)

Publication Number Publication Date
AT554101T true AT554101T (en) 2012-05-15

Family

ID=37762538

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06827481T AT554101T (en) 2005-11-01 2006-11-01 New activinrezeptor and applications thereof

Country Status (8)

Country Link
US (4) US8067562B2 (en)
EP (1) EP1943273B1 (en)
JP (4) JP5349966B2 (en)
AT (1) AT554101T (en)
AU (1) AU2006308614B2 (en)
CA (1) CA2627200C (en)
ES (1) ES2385581T3 (en)
WO (1) WO2007053775A1 (en)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4210897C1 (en) 1992-04-02 1993-08-12 Man Roland Druckmaschinen Ag, 6050 Offenbach, De
EP1581649B1 (en) 2002-12-20 2011-01-26 Amgen, Inc Binding agents which inhibit myostatin
US7709605B2 (en) 2004-07-23 2010-05-04 Acceleron Pharma Inc. ActRII receptor polypeptides, methods and compositions
US8067562B2 (en) * 2005-11-01 2011-11-29 Amgen Inc. Isolated nucleic acid molecule comprising the amino acid sequence of SEQ ID NO:1
CA2631013C (en) 2005-11-23 2019-06-11 Acceleron Pharma Inc. Activin-actriia antagonists and uses for promoting bone growth
US8128933B2 (en) 2005-11-23 2012-03-06 Acceleron Pharma, Inc. Method of promoting bone growth by an anti-activin B antibody
WO2008067480A2 (en) * 2006-11-29 2008-06-05 Nationwide Children's Hospital Myostatin inhibition for enhancing muscle and/or improving muscle function
WO2008076437A2 (en) 2006-12-18 2008-06-26 Acceleron Pharma Inc. Activin-actrii antagonists and uses for increasing red blood cell levels
US8895016B2 (en) 2006-12-18 2014-11-25 Acceleron Pharma, Inc. Antagonists of activin-actriia and uses for increasing red blood cell levels
TWI584815B (en) 2007-02-01 2017-06-01 艾瑟勒朗法瑪公司 Activin-actriia antagonists and uses for treating or preventing breast cancer
TWI548647B (en) 2007-02-02 2016-09-11 艾瑟勒朗法瑪公司 Variants derived from actriib and uses therefor
TWI667038B (en) 2007-02-09 2019-08-01 美商艾瑟勒朗法瑪公司 Pharmaceutical composition comprising an actriia-fc fusion protein; use of an actriia-fc fusion protein for treatment or prevention of cancer-related bone loss; use of an actriia-fc fusion protein for the treatment or prevention of multiple myeloma
EA201491231A8 (en) 2011-12-19 2015-01-30 Амген Инк. Options for activin receptor polypeptides and their application
US8501678B2 (en) 2007-03-06 2013-08-06 Atara Biotherapeutics, Inc. Variant activin receptor polypeptides and uses thereof
TWI573802B (en) 2007-03-06 2017-03-11 安美基公司 Variant activin receptor polypeptides and uses thereof
CN101861161B (en) 2007-09-18 2017-04-19 阿塞勒隆制药公司 Activin-ACTRIIA antagonists and uses for decreasing or inhibiting FSH secretion
DK2340031T3 (en) 2008-08-14 2019-07-15 Acceleron Pharma Inc Gdf customer for use of analysis treatment
KR101882521B1 (en) * 2009-08-13 2018-07-27 악셀레론 파마 인코포레이티드 Combined use of gdf traps and erythropoietin receptor activators to increase red blood cell levels
US8216997B2 (en) 2008-08-14 2012-07-10 Acceleron Pharma, Inc. Methods for increasing red blood cell levels and treating anemia using a combination of GDF traps and erythropoietin receptor activators
PT2370463T (en) * 2008-11-26 2016-11-04 Amgen Inc A stabilized variant of activin iib receptor
AU2013216639B2 (en) * 2008-11-26 2016-05-05 Amgen Inc. Variants of activin IIB receptor polypeptides and uses thereof
EP2387412A4 (en) 2009-01-13 2013-04-03 Acceleron Pharma Inc Methods for increasing adiponectin
MY153078A (en) * 2009-04-27 2014-12-31 Novartis Ag Compositions and methods for increasing muscle growth
CN102482339B (en) 2009-06-08 2015-06-17 阿塞勒隆制药公司 Methods for increasing thermogenic adipocytes
KR20180026795A (en) 2009-06-12 2018-03-13 악셀레론 파마 인코포레이티드 TRUNCATED ActRIIB-FC FUSION PROTEINS
EP3260130A3 (en) 2009-11-03 2018-02-07 Acceleron Pharma Inc. Methods for treating fatty liver disease
EP2501400B1 (en) 2009-11-17 2017-11-01 Acceleron Pharma, Inc. Actriib proteins and variants and uses therefore relating to utrophin induction for muscular dystrophy therapy
CN103221426B (en) 2010-08-16 2016-01-13 安姆根公司 In conjunction with the antibody of myostatin, composition and method
WO2012064771A1 (en) 2010-11-08 2012-05-18 Acceleron Pharma, Inc. Actriia binding agents and uses thereof
BR112014009528A8 (en) 2011-10-17 2019-12-10 Acceleron Pharma Inc methods and compositions for treating ineffective erythropoiesis
AU2013334659B2 (en) * 2012-10-24 2019-07-11 Celgene Corporation Biomarker for use in treating anemia
WO2014071158A1 (en) 2012-11-02 2014-05-08 Celgene Corporation Activin-actrii antagonists and uses for treating bone and other disorders
EP2983694A4 (en) 2013-04-08 2016-12-21 Harvard College Methods and compositions for rejuvenating skeletal muscle stem cells
US10260068B2 (en) * 2014-03-31 2019-04-16 Sumitomo Dainippon Pharma Co., Ltd. Prophylactic agent and therapeutic agent for fibrodysplasia ossificans progressiva
BR112016029226A2 (en) 2014-06-13 2017-10-17 Acceleron Pharma Inc methods and compositions for treating ulcers

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5750375A (en) 1988-01-22 1998-05-12 Zymogenetics, Inc. Methods of producing secreted receptor analogs and biologically active dimerized polypeptide fusions
US5567584A (en) 1988-01-22 1996-10-22 Zymogenetics, Inc. Methods of using biologically active dimerized polypeptide fusions to detect PDGF
US5885794A (en) 1991-05-10 1999-03-23 The Salk Institute For Biological Studies Recombinant production of vertebrate activin receptor polypeptides and identification of receptor DNAs in the activin/TGF-β superfamily
US20050186593A1 (en) 1991-05-10 2005-08-25 The Salk Institute For Biological Studies Cloning and recombinant production of CRF receptor(s)
US6162896A (en) 1991-05-10 2000-12-19 The Salk Institute For Biological Studies Recombinant vertebrate activin receptors
US6153407A (en) 1992-07-28 2000-11-28 Beth Israel Deaconess Medical Center Erythropoietin DNA having modified 5' and 3' sequences and its use to prepare EPO therapeutics
ES2201076T3 (en) 1993-03-19 2004-03-16 The Johns Hopkins University School Of Medicine Growth differentiation factor-8.
US6607884B1 (en) 1993-03-19 2003-08-19 The Johns Hopkins University School Of Medicine Methods of detecting growth differentiation factor-8
US6465239B1 (en) 1993-03-19 2002-10-15 The John Hopkins University School Of Medicine Growth differentiation factor-8 nucleic acid and polypeptides from aquatic species and non-human transgenic aquatic species
AT378407T (en) * 1994-04-29 2007-11-15 Curis Inc Morphogenic protein-specific cell surface receptors and their uses
US5994618A (en) 1997-02-05 1999-11-30 Johns Hopkins University School Of Medicine Growth differentiation factor-8 transgenic mice
US6656475B1 (en) 1997-08-01 2003-12-02 The Johns Hopkins University School Of Medicine Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same
US6891082B2 (en) 1997-08-01 2005-05-10 The Johns Hopkins University School Of Medicine Transgenic non-human animals expressing a truncated activintype II receptor
US6472179B2 (en) 1998-09-25 2002-10-29 Regeneron Pharmaceuticals, Inc. Receptor based antagonists and methods of making and using
US6660843B1 (en) 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
DE60027135T2 (en) 1999-01-21 2007-01-11 Metamorphix, Inc. Inhibitors for growth differentiation factor and its applications
JP4487376B2 (en) 2000-03-31 2010-06-23 味の素株式会社 Kidney disease treatment
US6812339B1 (en) * 2000-09-08 2004-11-02 Applera Corporation Polymorphisms in known genes associated with human disease, methods of detection and uses thereof
US20040223966A1 (en) 2002-10-25 2004-11-11 Wolfman Neil M. ActRIIB fusion polypeptides and uses therefor
EP1581649B1 (en) 2002-12-20 2011-01-26 Amgen, Inc Binding agents which inhibit myostatin
US8110665B2 (en) 2003-11-13 2012-02-07 Hanmi Holdings Co., Ltd. Pharmaceutical composition comprising an immunoglobulin FC region as a carrier
DK2239273T3 (en) 2003-11-13 2013-12-09 Hanmi Science Co Ltd Pharmaceutical composition comprising an immunoglobulin Fc region as a carrier
US7709605B2 (en) 2004-07-23 2010-05-04 Acceleron Pharma Inc. ActRII receptor polypeptides, methods and compositions
WO2006020884A2 (en) 2004-08-12 2006-02-23 Wyeth Combination therapy for diabetes, obesity, and cardiovascular diseases using gdf-8 inhibitors
AU2005289685B2 (en) 2004-09-24 2009-07-16 Amgen Inc. Modified Fc molecules
KR100754667B1 (en) 2005-04-08 2007-09-03 한미약품 주식회사 Immunoglobulin Fc fragment modified by non-peptide polymer and pharmaceutical composition comprising the same
US7963631B2 (en) * 2005-04-25 2011-06-21 Ulvac, Inc. Printhead maintenance station
US8067562B2 (en) * 2005-11-01 2011-11-29 Amgen Inc. Isolated nucleic acid molecule comprising the amino acid sequence of SEQ ID NO:1
CL2007002567A1 (en) 2006-09-08 2008-02-01 Amgen Inc Proteins isolated from a human link to activin.
TWI548647B (en) 2007-02-02 2016-09-11 艾瑟勒朗法瑪公司 Variants derived from actriib and uses therefor
TWI573802B (en) 2007-03-06 2017-03-11 安美基公司 Variant activin receptor polypeptides and uses thereof
CA2681177C (en) 2007-03-19 2019-08-20 National Research Council Of Canada Antagonists of ligands and uses thereof
CN101861161B (en) 2007-09-18 2017-04-19 阿塞勒隆制药公司 Activin-ACTRIIA antagonists and uses for decreasing or inhibiting FSH secretion
US8216997B2 (en) 2008-08-14 2012-07-10 Acceleron Pharma, Inc. Methods for increasing red blood cell levels and treating anemia using a combination of GDF traps and erythropoietin receptor activators
DK2340031T3 (en) 2008-08-14 2019-07-15 Acceleron Pharma Inc Gdf customer for use of analysis treatment
PT2370463T (en) 2008-11-26 2016-11-04 Amgen Inc A stabilized variant of activin iib receptor
EP2387412A4 (en) 2009-01-13 2013-04-03 Acceleron Pharma Inc Methods for increasing adiponectin
CN102482339B (en) 2009-06-08 2015-06-17 阿塞勒隆制药公司 Methods for increasing thermogenic adipocytes
US20120295814A1 (en) 2010-01-08 2012-11-22 The Brigham And Women's Hospital, Inc. CA-125 Immune Complexes as Biomarkers of Ovarian Cancer
MX2011011596A (en) 2010-03-31 2012-02-01 Keryx Biopharmaceuticals Inc Perifosine and capecitabine as a combined treatment for cancer.
JP2012171705A (en) * 2011-02-17 2012-09-10 Riso Kagaku Corp Printing apparatus
JP6155653B2 (en) * 2013-01-17 2017-07-05 株式会社寺岡精工 Label printer

Also Published As

Publication number Publication date
WO2007053775A1 (en) 2007-05-10
US8614292B2 (en) 2013-12-24
US20070117130A1 (en) 2007-05-24
US20110281796A1 (en) 2011-11-17
JP2009513162A (en) 2009-04-02
ES2385581T3 (en) 2012-07-26
AU2006308614A1 (en) 2007-05-10
CA2627200A1 (en) 2007-05-10
US20140088008A1 (en) 2014-03-27
JP2013027391A (en) 2013-02-07
JP2016187361A (en) 2016-11-04
EP1943273A1 (en) 2008-07-16
US9284364B2 (en) 2016-03-15
US8067562B2 (en) 2011-11-29
JP5349966B2 (en) 2013-11-20
CA2627200C (en) 2013-09-10
JP2014195469A (en) 2014-10-16
AU2006308614B2 (en) 2011-11-17
JP6072731B2 (en) 2017-02-01
EP1943273B1 (en) 2012-04-18
US20160152683A1 (en) 2016-06-02

Similar Documents

Publication Publication Date Title
DK1888595T3 (en) Spiro-oxindole compounds and their applications as therapeutic agents
DK1893196T3 (en) Diarylhydantoin connection
DK1904104T3 (en) SP35 antibodies and their applications
DK1934179T3 (en) Methods and intermediates
DK1961744T3 (en) Compound containing basic groups and their use
DK1846445T3 (en) PYY agonists and their applications
DK2343320T3 (en) Anti-gitr antibodies and applications thereof
DK1803934T3 (en) micropump
FR2882061B1 (en) Elastic materials
FR2888850B1 (en) Novel anti-igf-ir antibodies and their applications
DK1988307T3 (en) Reducers
DK2059535T3 (en) Prlr-specific antibody and applications thereof
AT540035T (en) Spiro-2,4-pyrimidindiamine compounds and their uses
AT494480T (en) Compressor
DE502006005443D1 (en) Fan
DE602006018165D1 (en) In electrolum inanz installations
BRPI0717638A2 (en) Anticorpors and immunocused and uses for them
AT553124T (en) Oxyntomodulinanaloga and its effects on the frese behavior
AT401659T (en) Keyboard and keyboard arrangement
AT437307T (en) Spiral-refrigerant compressor
AT438041T (en) Bearing element
DK1954140T3 (en) Glycerollevulinetketals and their use
AT466822T (en) Wavy structure
BRPI0813244A2 (en) Compounds and its uses 708
AT525374T (en) Heteroarylsubstituted pyrroloe2,3-büpyridine and pyrroloä2,3-büpyrimidine as januskinaseinhibitors